Transgender therapy and relationship with bone disorders Chairperson: Bruno Muzzi Camargos ‣ Guidelines for hormonal therapy on transgender patients - Ariana Sierra Osorio ‣ From man to woman and from woman to man: Does it matter? - Andres Coy ‣ Densitometric acquisition, analysis and reporting - Bruno Muzzi Camargos ‣ Recommendations to maintain bone health on transgender patients - Adriana Medina Orjuella
Vitamin D deficiency and rheumatic diseases Chairperson: Panagiotis Athanassiou ‣ Vitamin D deficiency and autoimmunity - Ifigenia Kostoglou‑Athanassiou ‣ Vitamin D deficiency and rheumatoid arthritis - Yannis Dionyssiotis ‣ Vitamin D deficiency and systemic lupus erythematosus - Panagiotis Athanassiou ‣ Vitamin D receptor polymorphisms and autoimmune diseases - Lambros Athanassiou
Global Impact of Bone Health TeleECHO: The Prototype for Technology Enabled Collaborative Learning for Skeletal Healthcare Chairperson: E. Michael Lewiecki ‣ Introduction and Background of Bone Health TeleECHO - E. Michael Lewiecki ‣ National University of Ireland Galway Bone Health TeleECHO - John J. Carey ‣ Bone Health TeleECHO Moscow - Zhanna Belaya ‣ Rare Bone Disease TeleECHO - Kassim Javaid
Artificial Intelligence (AI) in Musculoskeletal Imaging – A Paradigm Shift ‘ante portas’? Chairperson: Hans Peter Dimai ‣ AI in various modalities of musculoskeletal imaging (radiography, DXA, CT, MRT) - Ronald M. Summers ‣ Knee osteoarthritis assessment by AI increases physicians’ agreement rate and accuracy - Stefan Nehrer
Managing fracture risk in primary care: roles and requirements Chairperson: Z. Paskins ‣ Current challenges for primary care osteoporosis management - Z. Paskins ‣ What osteoporosis care looks like in current UK general practice - Elizabeth Cottrell ‣ Primary care and the management of special groups at risk of fracture - Elizabeth Cottrell ‣ How primary care osteoporosis management can be improved - John Edwards ‣ Summing up: Challenges and opportunities for better integration of primary and secondary care - Z. Paskins ‣ Close - Z. Paskins
Nationwide identification of vertebral fragility fractures: Collaborating with Radiology Chairperson: Bo Abrahamsen ‣ Collaboration for better patient outcomes in vertebral fracture - Jill Griffin ‣ National audit on the reporting of incidentally found vertebral fractures in routine radiology practice - Nadia Mahmood ‣ Evaluation of the identification of vertebral fractures within fracture liaison services- looking to the future - Kassim Javaid ‣ Evaluating the demand on fracture liaison services with effective identification of vertebral fractures - Helen Glenn
Winning the political case for change – launch of a policy toolkit for osteoporosis and fragility fractures Chairperson: Ed Harding ‣ Welcome and introduction - Ed Harding ‣ What we know: critical challenges in osteoporosis and fragility fracture care - Cyrus Cooper ‣ The way forward: political actions needed to improve prevention and care of osteoporosis and fragility fractures - John Bowis ‣ Next steps for the network - Jody Tate ‣ Discussion - With Ed Harding, Cyrus Cooper and John Bowis, moderated by Jody Tate ‣ Concluding remarks - Jody Tate
Targeting bone and muscle: Novel therapeutic approaches to osteosarcopenia Chairperson: Serge Ferrari ‣ RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass from mice to humans - Nicolas Bonnet ‣ Old and new roles of amino acids and amino butyric acids in musculoskeletal diseases - Marco Brotto ‣ Fat as a therapeutic target in osteosarcopenia - Gustavo Duque
Joint Symposium of the IOF Skeletal Rare Diseases Working Group (SRD-WG) and the a European Reference Network on Rare Bone Diseases (ERN-BOND) Chairperson: Maria Luisa Brandi ‣ Diversity on the pathophysiology of increased bone fragility in rare bone diseases - Naveen Hamdy ‣ Quality of bone in Osteogenesis Imperfecta patients - Luca Sangiorgi
The importance of explanations: improving communication about osteoporosis and osteoarthritis to support uptake of evidence-based treatments Chairperson: John Edwards ‣ Evidence-care gap in osteoporosis and osteoarthritis - John Edwards ‣ What do we already know about how to frame explanations? - Z. Paskins ‣ Targeting communication in the clinician-patient consultation to improve uptake of fracture prevention treatments: early findings from the iFraP study - Z. Paskins ‣ What patients with osteoarthritis want and need to know to support them to undertake self-management: early findings from the PEP-OA study - Elizabeth Cottrell ‣ Lessons for clinical practice and research - John Edwards ‣ Close - John Edwards
CTF getting to gold framework Chairperson: Kassim Javaid ‣ Presentation of the Getting to Gold programme framework and milestones - Kassim Javaid ‣ Evaluation of the mentorship programme - Monica Calo ‣ Evaluation of the mentorship programme- mentees perspective - Andrea Olascoaga ‣ Next steps for Getting to Gold - Kassim Javaid
Stronger Together: Innovative Collaborative Initiatives to Improve Osteoporosis Care The Asia Pacific Consortium on Osteoporosis and the Asia Pacific Fragility Fracture Alliance Chairperson: John A. Kanis ‣ The Burden of Osteoporosis and Fragility Fractures in Asia Pacific - Joon‑Kiong Lee ‣ Asia Pacific Consortium on Osteoporosis: Development of The Framework - Manju Chandran ‣ Asia Pacific Fragility Fracture Alliance: Working group outputs - Derrick Chan ‣ Q&A Session
Inter-relation between bone, muscle, strength and fat in older adults: influence of nutrition and exercise Chairperson: Mylène Aubertin‑Leheudre ‣ Influence of initial protein intake on bone density and architecture in dynapenic-obese older adults - Fanny Buckinx ‣ Preserving Body & muscle composition in Obese-Osteopenic Older Women: High-Intensity Interval Training a potential intervention? - Mylène Aubertin‑Leheudre ‣ Physical performance in obese-osteopenic elderly women: high-intensity interval training more efficient than continuous aerobic training? - Bertrand Fougère
Bone Health in Patients with Chronic Kidney Disease Chairperson: Matthew Abramowitz ‣ Bone disorders, mineral metabolism, and vascular calcification in chronic kidney disease - Wei Chen ‣ Bone disease, muscle dysfunction, and sarcopenia in chronic kidney disease - Matthew Abramowitz
Patient-reported outcomes in sarcopenia Chairperson: Yves Rolland, Olivier Bruyère ‣ Welcome and introduction - Olivier Bruyère ‣ Quality of life in sarcopenia : an update - Charlotte Beaudart ‣ Overview of generic and specific Patient Reported Outcome Measures (PROMs) in sarcopenia - Anton Geerinck ‣ Conclusion - Yves Rolland ‣ Questions
DENOSUMAB discontinuation: Trends, challenges, ups-and-downs Chairperson: Bruno Muzzi Camargos ‣ Vertebral Fracture Following D-Mab Discontinuation: Supporting Data - Oscar Rosero Olarte ‣ Pathophysiology Of The Osteoclastic “Flare” After Discontinuation Adriana - Medina Orjuella ‣ Biochemichal And Imaging Assessment: Ups And Downs - Bruno Muzzi Camargos ‣ Bone Loss After D-Mab Discontinuation In 150 Patients - Maria Belen Zanchetta ‣ D-Mab Patient Management In The Clinical Setting: Stepping On The Right Foot - Luis Fernando Vidal Neira
When a DXA is indicated, a VFA is also recommended Chairperson: Willem Lems, Kristina Åkesson ‣ Introduction - Willem Lems ‣ Clinical relevance of vertebral fractures - Julien Paccou ‣ Radiological diagnosis of vertebral fractures with VFA - Jean Zhang ‣ Advantages and limitations of VFA - Manju Chandran ‣ Conclusion - Kristina Åkesson
Fragility fractures in Sub-Saharan Africa: Time to break the myth! Chairperson: Celia Gregson ‣ Chairs introduction and setting the scene - Kate Ward ‣ Trends in fracture incidence in high-income countries - Bo Abrahamsen ‣ Breaking the myth in Sub-Saharan Africa – what do we know about fragility fracture? - Kate Ward ‣ Summary and wrap-up - Kate Ward
Female Bone Health: a gynecological approach on women's special conditions Chairperson: Adriana Orcesi Pedro ‣ Opening - Adriana Orcesi Pedro ‣ Update on management of low bone mass in young women - Adriana Orcesi Pedro ‣ Bone mass and fracture risk during pregnancy and lactation - Ben‑Hur Albergaria ‣ Evaluation and management of osteopenia and osteoporosis in breast and gynecological cancer survivors - Marcelo Luis Steiner
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 1: Defining Frailty Chairperson: Dominique Verté ‣ Introduction - Ivan Bautmans ‣ Towards a uniform language of Frailty - Roberta Vella‑Azzopardi ‣ Fatigue in the frailty constructs - Veerle Knoop ‣ The disability paradox in the frailty constructs - Axelle Costenoble ‣ Measures of cognition in the frailty constructs - Ellen Gorus
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 2: First results from the BUTTERFLY study Chairperson: Dominique Verté ‣ Introduction - Ivan Bautmans ‣ General profile of the Butterfly participants - Aziz Debain ‣ Validated equations for estimating body composition in the oldest old - Jona Van den Broeck ‣ Immunosenescence signatures in pre-frailty - Rose Njemini
Clinical diagnostics of chronic and acute pain. Multimodal approach Chairperson: Olga Kurushina ‣ Acute and chronic pain: The difference between diagnostic approaches - Olga Kurushina ‣ Pain and biomechanics - Alexander Barulin ‣ Features of clinical diagnosis of cervicogenic headache - Anna Drushlyakova ‣ Diagnosis of temporomandibular disorders in patients with chronic facial pain - Bogdan Kalinchenko
Awareness, Risk factors and Early Detection of Osteoporosis in Turkish Postmenopausal Female Patients Chairperson: Pinar Borman, Vesile Sepici ‣ The Awareness and Knowledge of Osteoporosis and Risk factors in a group Turkish Geriatric Patients - Belgin Karaoglan ‣ The Knowledge about Osteoporosis in a Group of Turkish Females: Relationship with Quantitative Ultrasonographic Scores - Pinar Borman ‣ Laboratory overview of bone turnover markers - Aylin Sepici Dincel ‣ Risk Factors of osteoporosis and osteoporotic fractures - Vesile Sepici
Controversies regarding the management of gout and asymptomatic hyperuricemia Chairperson: Razvan Adrian Ionescu ‣ Uric acid - Friend or foe? - Mihai Bojinca ‣ Asymptomatic hyperuricemia - The hidden realm (Imaging clue) - Florentin Ananu Vreju ‣ Bone mineral density in hyperuricemia and gout - Collateral damage? - Claudiu Avram ‣ Gout treatment - As easy as it seems? - Razvan Adrian Ionescu
The microcirculation abnormalities in osteoporosis and osteoarthritis Chairperson: Sekib Sokolovic, Alena Rudenko ‣ Introduction - Sekib Sokolovic ‣ Angiogenesis and Bone - Gerold Holzer ‣ Vascular pathology and Osteoarthritis, Imaging of Microcirculation - Juan Jose Scali ‣ The Microcirculation abnormalities in Osteoporosis and Osteoarthritis - Sekib Sokolovic
Non-pharmacological approaches in the management of osteoporosis Chairperson: Yesim Gokce Kutsal ‣ How to modify life-style? - Yesim Gokce Kutsal ‣ The role of exercises: What type of exercise when? - Jale Meray ‣ Are orthoses and physical modalities effective for osteoporosis and/or osteoporotic fractures? - Ayse A. Kucukdeveci ‣ Case presentations - Yesim Kirazli
Relevance of body composition in chronic diseases Chairperson: Mislav Radić ‣ Association of body composition with disease activity in rheumatoid arthritis - Mislav Radić ‣ Relationship of body composition with osteoporosis - Tonko Vlak ‣ Impact of disability on body composition in multiple sclerosis - Ozren Polasek
Osteosarcopenia school Chairperson: Mark Lissens, Yannis Dionyssiotis ‣ Osteosarcopenia - Ifigenia Kostoglou‑Athanassiou ‣ Neurogenic osteoporosis due to sarcopenia in post poliomyelitis patients - Mark Lissens ‣ Osteosarcopenia school - Yannis Dionyssiotis
Chairperson: Bruno Muzzi Camargos
‣ Guidelines for hormonal therapy on transgender patients - Ariana Sierra Osorio
‣ From man to woman and from woman to man: Does it matter? - Andres Coy
‣ Densitometric acquisition, analysis and reporting - Bruno Muzzi Camargos
‣ Recommendations to maintain bone health on transgender patients - Adriana Medina Orjuella
Vitamin D deficiency and rheumatic diseases
Chairperson: Panagiotis Athanassiou
‣ Vitamin D deficiency and autoimmunity - Ifigenia Kostoglou‑Athanassiou
‣ Vitamin D deficiency and rheumatoid arthritis - Yannis Dionyssiotis
‣ Vitamin D deficiency and systemic lupus erythematosus - Panagiotis Athanassiou
‣ Vitamin D receptor polymorphisms and autoimmune diseases - Lambros Athanassiou
Global Impact of Bone Health TeleECHO: The Prototype for Technology Enabled Collaborative Learning for Skeletal Healthcare
Chairperson: E. Michael Lewiecki
‣ Introduction and Background of Bone Health TeleECHO - E. Michael Lewiecki
‣ National University of Ireland Galway Bone Health TeleECHO - John J. Carey
‣ Bone Health TeleECHO Moscow - Zhanna Belaya
‣ Rare Bone Disease TeleECHO - Kassim Javaid
Artificial Intelligence (AI) in Musculoskeletal Imaging – A Paradigm Shift ‘ante portas’?
Chairperson: Hans Peter Dimai
‣ AI in various modalities of musculoskeletal imaging (radiography, DXA, CT, MRT) - Ronald M. Summers
‣ Knee osteoarthritis assessment by AI increases physicians’ agreement rate and accuracy - Stefan Nehrer
Managing fracture risk in primary care: roles and requirements
Chairperson: Z. Paskins
‣ Current challenges for primary care osteoporosis management - Z. Paskins
‣ What osteoporosis care looks like in current UK general practice - Elizabeth Cottrell
‣ Primary care and the management of special groups at risk of fracture - Elizabeth Cottrell
‣ How primary care osteoporosis management can be improved - John Edwards
‣ Summing up: Challenges and opportunities for better integration of primary and secondary care - Z. Paskins
‣ Close - Z. Paskins
Nationwide identification of vertebral fragility fractures: Collaborating with Radiology
Chairperson: Bo Abrahamsen
‣ Collaboration for better patient outcomes in vertebral fracture - Jill Griffin
‣ National audit on the reporting of incidentally found vertebral fractures in routine radiology practice - Nadia Mahmood
‣ Evaluation of the identification of vertebral fractures within fracture liaison services- looking to the future - Kassim Javaid
‣ Evaluating the demand on fracture liaison services with effective identification of vertebral fractures - Helen Glenn
Winning the political case for change – launch of a policy toolkit for osteoporosis and fragility fractures
Chairperson: Ed Harding
‣ Welcome and introduction - Ed Harding
‣ What we know: critical challenges in osteoporosis and fragility fracture care - Cyrus Cooper
‣ The way forward: political actions needed to improve prevention and care of osteoporosis and fragility fractures - John Bowis
‣ Next steps for the network - Jody Tate
‣ Discussion - With Ed Harding, Cyrus Cooper and John Bowis, moderated by Jody Tate
‣ Concluding remarks - Jody Tate
Targeting bone and muscle: Novel therapeutic approaches to osteosarcopenia
Chairperson: Serge Ferrari
‣ RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass from mice to humans - Nicolas Bonnet
‣ Old and new roles of amino acids and amino butyric acids in musculoskeletal diseases - Marco Brotto
‣ Fat as a therapeutic target in osteosarcopenia - Gustavo Duque
Joint Symposium of the IOF Skeletal Rare Diseases Working Group (SRD-WG) and the a European Reference Network on Rare Bone Diseases (ERN-BOND)
Chairperson: Maria Luisa Brandi
‣ Diversity on the pathophysiology of increased bone fragility in rare bone diseases - Naveen Hamdy
‣ Quality of bone in Osteogenesis Imperfecta patients - Luca Sangiorgi
The importance of explanations: improving communication about osteoporosis and osteoarthritis to support uptake of evidence-based treatments
Chairperson: John Edwards
‣ Evidence-care gap in osteoporosis and osteoarthritis - John Edwards
‣ What do we already know about how to frame explanations? - Z. Paskins
‣ Targeting communication in the clinician-patient consultation to improve uptake of fracture prevention treatments: early findings from the iFraP study - Z. Paskins
‣ What patients with osteoarthritis want and need to know to support them to undertake self-management: early findings from the PEP-OA study - Elizabeth Cottrell
‣ Lessons for clinical practice and research - John Edwards
‣ Close - John Edwards
CTF getting to gold framework
Chairperson: Kassim Javaid
‣ Presentation of the Getting to Gold programme framework and milestones - Kassim Javaid
‣ Evaluation of the mentorship programme - Monica Calo
‣ Evaluation of the mentorship programme- mentees perspective - Andrea Olascoaga
‣ Next steps for Getting to Gold - Kassim Javaid
Stronger Together: Innovative Collaborative Initiatives to Improve Osteoporosis Care The Asia Pacific Consortium on Osteoporosis and the Asia Pacific Fragility Fracture Alliance
Chairperson: John A. Kanis
‣ The Burden of Osteoporosis and Fragility Fractures in Asia Pacific - Joon‑Kiong Lee
‣ Asia Pacific Consortium on Osteoporosis: Development of The Framework - Manju Chandran
‣ Asia Pacific Fragility Fracture Alliance: Working group outputs - Derrick Chan
‣ Q&A Session
Inter-relation between bone, muscle, strength and fat in older adults: influence of nutrition and exercise
Chairperson: Mylène Aubertin‑Leheudre
‣ Influence of initial protein intake on bone density and architecture in dynapenic-obese older adults - Fanny Buckinx
‣ Preserving Body & muscle composition in Obese-Osteopenic Older Women: High-Intensity Interval Training a potential intervention? - Mylène Aubertin‑Leheudre
‣ Physical performance in obese-osteopenic elderly women: high-intensity interval training more efficient than continuous aerobic training? - Bertrand Fougère
Bone Health in Patients with Chronic Kidney Disease
Chairperson: Matthew Abramowitz
‣ Bone disorders, mineral metabolism, and vascular calcification in chronic kidney disease - Wei Chen
‣ Bone disease, muscle dysfunction, and sarcopenia in chronic kidney disease - Matthew Abramowitz
Patient-reported outcomes in sarcopenia
Chairperson: Yves Rolland, Olivier Bruyère
‣ Welcome and introduction - Olivier Bruyère
‣ Quality of life in sarcopenia : an update - Charlotte Beaudart
‣ Overview of generic and specific Patient Reported Outcome Measures (PROMs) in sarcopenia - Anton Geerinck
‣ Conclusion - Yves Rolland
‣ Questions
DENOSUMAB discontinuation: Trends, challenges, ups-and-downs
Chairperson: Bruno Muzzi Camargos
‣ Vertebral Fracture Following D-Mab Discontinuation: Supporting Data - Oscar Rosero Olarte
‣ Pathophysiology Of The Osteoclastic “Flare” After Discontinuation Adriana - Medina Orjuella
‣ Biochemichal And Imaging Assessment: Ups And Downs - Bruno Muzzi Camargos
‣ Bone Loss After D-Mab Discontinuation In 150 Patients - Maria Belen Zanchetta
‣ D-Mab Patient Management In The Clinical Setting: Stepping On The Right Foot - Luis Fernando Vidal Neira
When a DXA is indicated, a VFA is also recommended
Chairperson: Willem Lems, Kristina Åkesson
‣ Introduction - Willem Lems
‣ Clinical relevance of vertebral fractures - Julien Paccou
‣ Radiological diagnosis of vertebral fractures with VFA - Jean Zhang
‣ Advantages and limitations of VFA - Manju Chandran
‣ Conclusion - Kristina Åkesson
Fragility fractures in Sub-Saharan Africa: Time to break the myth!
Chairperson: Celia Gregson
‣ Chairs introduction and setting the scene - Kate Ward
‣ Trends in fracture incidence in high-income countries - Bo Abrahamsen
‣ Breaking the myth in Sub-Saharan Africa – what do we know about fragility fracture? - Kate Ward
‣ Summary and wrap-up - Kate Ward
Female Bone Health: a gynecological approach on women's special conditions
Chairperson: Adriana Orcesi Pedro
‣ Opening - Adriana Orcesi Pedro
‣ Update on management of low bone mass in young women - Adriana Orcesi Pedro
‣ Bone mass and fracture risk during pregnancy and lactation - Ben‑Hur Albergaria
‣ Evaluation and management of osteopenia and osteoporosis in breast and gynecological cancer survivors - Marcelo Luis Steiner
Sarcopenic obesity
Chairperson: Ifigenia Kostoglou‑Athanassiou
‣ Sarcopenia. Diagnosis and evaluation - Panagiotis Athanassiou
‣ Sarcopenia and nutrition - Lambros Athanassiou
‣ Sarcopenic obesity. Definition and pathophysiology - Ifigenia Kostoglou‑Athanassiou
‣ Sarcopenic obesity. Management - Yannis Dionyssiottis
‣ Discussion
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 1: Defining Frailty
Chairperson: Dominique Verté
‣ Introduction - Ivan Bautmans
‣ Towards a uniform language of Frailty - Roberta Vella‑Azzopardi
‣ Fatigue in the frailty constructs - Veerle Knoop
‣ The disability paradox in the frailty constructs - Axelle Costenoble
‣ Measures of cognition in the frailty constructs - Ellen Gorus
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 2: First results from the BUTTERFLY study
Chairperson: Dominique Verté
‣ Introduction - Ivan Bautmans
‣ General profile of the Butterfly participants - Aziz Debain
‣ Validated equations for estimating body composition in the oldest old - Jona Van den Broeck
‣ Immunosenescence signatures in pre-frailty - Rose Njemini
Clinical diagnostics of chronic and acute pain. Multimodal approach
Chairperson: Olga Kurushina
‣ Acute and chronic pain: The difference between diagnostic approaches - Olga Kurushina
‣ Pain and biomechanics - Alexander Barulin
‣ Features of clinical diagnosis of cervicogenic headache - Anna Drushlyakova
‣ Diagnosis of temporomandibular disorders in patients with chronic facial pain - Bogdan Kalinchenko
Awareness, Risk factors and Early Detection of Osteoporosis in Turkish Postmenopausal Female Patients
Chairperson: Pinar Borman, Vesile Sepici
‣ The Awareness and Knowledge of Osteoporosis and Risk factors in a group Turkish Geriatric Patients - Belgin Karaoglan
‣ The Knowledge about Osteoporosis in a Group of Turkish Females: Relationship with Quantitative Ultrasonographic Scores - Pinar Borman
‣ Laboratory overview of bone turnover markers - Aylin Sepici Dincel
‣ Risk Factors of osteoporosis and osteoporotic fractures - Vesile Sepici
Controversies regarding the management of gout and asymptomatic hyperuricemia
Chairperson: Razvan Adrian Ionescu
‣ Uric acid - Friend or foe? - Mihai Bojinca
‣ Asymptomatic hyperuricemia - The hidden realm (Imaging clue) - Florentin Ananu Vreju
‣ Bone mineral density in hyperuricemia and gout - Collateral damage? - Claudiu Avram
‣ Gout treatment - As easy as it seems? - Razvan Adrian Ionescu
The microcirculation abnormalities in osteoporosis and osteoarthritis
Chairperson: Sekib Sokolovic, Alena Rudenko
‣ Introduction - Sekib Sokolovic
‣ Angiogenesis and Bone - Gerold Holzer
‣ Vascular pathology and Osteoarthritis, Imaging of Microcirculation - Juan Jose Scali
‣ The Microcirculation abnormalities in Osteoporosis and Osteoarthritis - Sekib Sokolovic
Non-pharmacological approaches in the management of osteoporosis
Chairperson: Yesim Gokce Kutsal
‣ How to modify life-style? - Yesim Gokce Kutsal
‣ The role of exercises: What type of exercise when? - Jale Meray
‣ Are orthoses and physical modalities effective for osteoporosis and/or osteoporotic fractures? - Ayse A. Kucukdeveci
‣ Case presentations - Yesim Kirazli
Relevance of body composition in chronic diseases
Chairperson: Mislav Radić
‣ Association of body composition with disease activity in rheumatoid arthritis - Mislav Radić
‣ Relationship of body composition with osteoporosis - Tonko Vlak
‣ Impact of disability on body composition in multiple sclerosis - Ozren Polasek
Osteosarcopenia school
Chairperson: Mark Lissens, Yannis Dionyssiotis
‣ Osteosarcopenia - Ifigenia Kostoglou‑Athanassiou
‣ Neurogenic osteoporosis due to sarcopenia in post poliomyelitis patients - Mark Lissens
‣ Osteosarcopenia school - Yannis Dionyssiotis